John E. Leonard - 01 Apr 2022 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Signature
/s/ Scott E. Royer, Attorney-in-Fact for John E. Leonard
Issuer symbol
VCNX
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 16:36:15 UTC
Next filing
03 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 2,258 01 Apr 2022 Direct
holding VCNX Common Stock 1,014 01 Apr 2022 By John Leonard Consulting, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 01 Apr 2022 Common Stock 16,000 $1.29 Direct F5
holding VCNX Stock Option (Right to Buy) 23,150 01 Apr 2022 Common Stock 23,150 $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 3,062 01 Apr 2022 Common Stock 3,062 $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 3,000 01 Apr 2022 Common Stock 3,000 $3.90 Direct F2
holding VCNX Stock Option (Right to Buy) 4,000 01 Apr 2022 Common Stock 4,000 $6.07 Direct F3
holding VCNX Stock Option (Right to Buy) 8,000 01 Apr 2022 Common Stock 8,000 $2.93 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable in full as of the date of this report.
F2 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.
F3 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
F4 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F5 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.